drugset / Trial / NCT05379634
A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Nipocalimab versus placebo in participants with active idiopathic inflammatory myopathies (IIM).
Timeline
- Start
- 2022-07-05
- Primary completion
- 2025-09-04
- Completion
- 2026-09-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nipocalimab | Monoclonal antibody | — | Intravenous |
| Background | Prednisone | Other / unclassified | — | Oral |